#msg-15351807 cites how Roche acquired crenezumab—the protagonist of the story in #msg-75598892—from a rarely mentioned biotech company based in Lausanne, Switzerland.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”